Joe Rogan joins Trump as president signs EO to fast-track psychedelic treatment research

President Trump signed an executive order to accelerate access to psychedelic-based medical research and treatments while Joe Rogan stood with him; he directed senior health officials to review the effort.

President Donald Trump signed an executive order in the Oval Office aimed at accelerating access to medical research and treatments based on psychedelic drugs. Podcaster Joe Rogan was present at the signing along with Health and Human Services Secretary Robert F. Kennedy Jr., Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz, and FDA Commissioner Marty Makary. Trump described the action as moving to "dramatically accelerate" research and said he ordered deputies to look into fast-tracking treatments after contacts including a call from Rogan. Rogan said he had texted the president about a specific drug, Ibogaine, and cited studies he believes show high rates of treatment response. Key details: - The executive order is titled "Accelerating Medical Treatments for Serious Mental Illness." - Joe Rogan was at the signing and later said he texted President Trump about Ibogaine. - Trump said he instructed Robert F. Kennedy Jr., Dr. Mehmet Oz, Marty Makary and NIH Director Jay Bhattacharya to look into the matter. - The president described the move as intended to speed access to experimental psychedelic-based treatments and research. - Rogan said studies he referenced report that more than 80 percent of people with opioid addiction who take one dose of Ibogaine are free of that addiction, as reported by him. Summary: Officials named by the president have been asked to review and potentially accelerate research and access to psychedelic-based treatments. Undetermined at this time.